age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
69.00195
|
female
| 1
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 0
| 160,610.125
| 98,081.5625
| null | 41.666657
|
white
| 31.199219
| 37
| 0.573975
| 0.462952
| 11
| 0
| 0
|
no
| 0.5
| 0.2
|
dnr after sadm
| 19
| 96
| 19.699219
| 110
| 10
| 36.59375
| 290
| 2.699707
| 7.699219
| 2
| 151
| 7.459961
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 20
| 1
|
74.31299
|
female
| 0
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 6
|
under $11k
| 0
| 27,789.391
| 19,155.1562
| null | 19
|
white
| 33
| 56
| 0.460999
| 0.258972
| 11
| 0
| 0
|
no
| null | null |
no dnr
| 15
| 72
| 5.799805
| 124
| 31
| 35.5
| 176
| 2.899902
| null | 0.399963
| 138
| 7.459961
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 40
| 1
|
66.18994
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 2
| 10
|
under $11k
| 0
| 6,248
| 4,065.4219
| null | 6
|
black
| 27
| 16
| 0.630981
| 0.319946
| 1
| 1
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 7
| 101
| 11.798828
| 64
| 16
| 37.39844
| null | 2.5
| null | 0.899902
| 136
| null | null | null | null | 1
| 1
| null | 1
| 89
| 1
|
58.89697
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 91,730.875
| 65,269.1562
| null | 23.5
|
white
| 18.296875
| 14
| 0.849976
| 0.79895
| 12
| 0
| 0
|
no
| 0.5
| 0.25
|
no dnr
| 25
| 72
| 11.199219
| 74
| 8
| 39
| 266.625
| null | null | 0.5
| 135
| 7.459961
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,583
| 0
|
65.83398
|
male
| 1
| 7
|
Coma
|
Coma
| 1
| 11
|
$11-$25k
| 44
| 24,014.984
| 16,735.875
| null | 32
|
black
| 23.796875
| 28
| 0.491943
| 0.419983
| 1
| 0
| 0
|
no
| 0.25
| 0.2
|
dnr after sadm
| 5
| 75
| 6.799805
| 11
| 10
| 39.29688
| 386.625
| 3.099609
| 0.599976
| 1.5
| 142
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
57.487
|
male
| 1
| 37
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 11
|
under $11k
| 0
| 122,004.25
| 77,422.375
| null | 38.25
|
white
| 18.296875
| 15
| 0.790894
| 0.721924
| 2
| 0
| 0
|
yes
| 0.8
| 0.5
|
dnr after sadm
| 24
| 70
| 10
| 100
| 9
| 36.19531
| 226.65625
| null | null | 0.899902
| 139
| 7.419922
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 37
| 1
|
70.65295
|
male
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 5
| null | 0
| 19,755.547
| 13,855.2266
| null | 10
|
black
| 23
| 32
| 0.79895
| 0.675903
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
no dnr
| 18
| 77
| 9.798828
| 72
| 26
| 36.79688
| 225
| 2.399902
| 0.899902
| 1
| 134
| 7.429688
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.611816
| 1,574
| 0
|
53.185
|
male
| 0
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 41
| 33,711.281
| 21,372.6719
| null | 39.5
|
black
| 43
| 62
| 0.046997
| 0.014
| 2
| 1
| 0
|
yes
| 0.7
| 0.5
|
no dnr
| 8
| 48
| 13
| 52
| 30
| 35.19531
| 104
| 2.099609
| 0.699951
| 2.399902
| 136
| 7.339844
| null | null | null | null | null |
<2 mo. follow-up
| 2.638184
| 17
| 1
|
77.63696
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 9,904.242
| 6,551.9062
| null | 11.5
|
white
| 46
| 67
| 0.195984
| 0.103989
| 1
| 1
| 1
|
no
| 0.15
| 0.1
|
dnr after sadm
| 1
| 37
| 26
| 96
| 38
| 35.79688
| 108.32812
| null | null | 1.699951
| 141
| 7.129883
| null | null | null | null | null |
<2 mo. follow-up
| 4.786133
| 10
| 1
|
31.59799
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
under $11k
| 0
| 156,964.25
| 115,626.062
| null | 15.5
|
white
| 31.199219
| 51
| 0.744995
| 0.664917
| 38
| 1
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 11
| 145
| 4.699219
| 64
| 28
| 36.39844
| 132.5
| 2.099609
| 0.399963
| 5.199219
| 142
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 747
| 1
|
59.13998
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 17
|
>$50k
| 0
| 6,011.648
| 3,880.0293
| null | 18
|
white
| 22.597656
| 12
| 0.598999
| 0.280945
| 1
| 0
| 0
|
metastatic
| 0.4
| 0
|
dnr after sadm
| 1
| 87
| 11
| 120
| 24
| 36.29688
| null | null | 0.199982
| 0.599976
| 135
| null | null | null | null | 0
| 5
|
no(M2 and SIP pres)
| 5
| 164
| 1
|
47.99698
|
male
| 0
| 117
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 337,299.25
| 222,272.5
| null | 33.5
|
white
| 28.296875
| 22
| 0.817993
| 0.704956
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 117
| 62
| 14.199219
| 126
| 27
| 38.29688
| 384
| 3
| 1.099854
| 0.799927
| 128
| 7.449219
| null | null | null | null | null | null | 2.044434
| 1,572
| 0
|
61.15298
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 4
|
under $11k
| 0
| 6,116.449
| 4,469.4336
| null | 13
|
white
| 18.699219
| 32
| 0.884888
| 0.807983
| 1
| 1
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 6
| 60
| 7.199219
| 62
| 36
| 35.89844
| null | null | null | 1.099854
| 139
| 7.399414
| null | null | null | 2
| null |
no(M2 and SIP pres)
| 1.839
| 1,321
| 1
|
64.07397
|
male
| 1
| 14
|
Lung Cancer
|
Cancer
| 1
| 8
|
under $11k
| 0
| 55,642.438
| 37,272.6562
| null | 30.666656
|
black
| 42.59375
| 58
| 0.038994
| 0
| 4
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 12
| 73
| 28.699219
| 114
| 27
| 36
| 123.32812
| 3.099609
| 2.5
| 6.199219
| 135
| 7.379883
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
60.73398
|
male
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 6
|
$11-$25k
| 26
| 98,783.438
| 61,616.1562
| null | 31.333328
|
white
| 26.796875
| 27
| 0.622925
| 0.518921
| 9
| 0
| 0
|
no
| null | null |
no dnr
| 24
| 71
| 19.199219
| 114
| 8
| 38.09375
| 155
| 2.899902
| 3
| 1.099854
| 132
| 7.369141
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,572
| 0
|
38.27499
|
female
| 0
| 145
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
under $11k
| 37
| 218,732.875
| 141,284.625
| null | 35.5
|
black
| 29
| 36
| 0.720947
| 0.635986
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 145
| 147
| 17.597656
| 134
| 12
| 38.5
| 160
| 2.299805
| 1.299805
| 0.599976
| 130
| 7.359375
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.256348
| 1,572
| 0
|
43.53998
|
male
| 0
| 21
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 25,725.641
| 16,881.0312
| null | 14.666664
|
black
| 25.699219
| 32
| 0.566895
| 0.244995
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 21
| 77
| 6.399414
| 124
| 38
| 39.89844
| 376.1875
| null | 2.399902
| 0.5
| 141
| 7.459961
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 38
| 1
|
35.66898
|
female
| 0
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 158,145.75
| 99,069.125
| null | 46.5
|
white
| 42.398438
| 56
| 0.53894
| 0.424988
| 3
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 39
| 49
| 19.699219
| 144
| 48
| 39.59375
| 55
| 2.799805
| 0.5
| 0.799927
| 135
| 7.40918
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,568
| 0
|
56.81598
|
female
| 1
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 9
|
under $11k
| 0
| 12,576.898
| 8,586.6719
| null | 25
|
white
| 18.199219
| 26
| 0.876953
| 0.795898
| 5
| 1
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 5
| 115
| 7.799805
| 72
| 24
| 36.19531
| 300
| null | null | 1.599854
| 133
| 7.449219
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
42.14099
|
male
| 0
| 27
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 88,426.188
| 64,598.4375
| null | 27
|
white
| 14.898438
| 22
| 0.941895
| 0.901978
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 27
| 59
| 7.399414
| 74
| 24
| 37.79688
| 376.625
| null | 1
| 1.099854
| 132
| 7.469727
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,567
| 0
|
47.62198
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 3,364.6
| 2,296.4531
| null | 13
|
white
| 15.099609
| 12
| 0.866943
| 0.701904
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 5
| 78
| 3.599609
| 64
| 16
| 36.19531
| null | 3.699707
| 1.699951
| 0.799927
| 136
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.680176
| 288
| 1
|
65.20697
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 4,139.348
| 3,229.4004
| null | 7
|
black
| 21.398438
| 48
| 0.844971
| 0.745972
| 1
| 1
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 7
| 100
| 5.199219
| 80
| 32
| 36.39844
| 161.875
| 3.399902
| 2.199707
| 1.099854
| 136
| 7.399414
| null | null | null | 4
| 4
|
no(M2 and SIP pres)
| 4
| 1,566
| 0
|
75.07495
|
male
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
$25-$50k
| 0
| 75,079.25
| 47,504.6562
| null | 34.666657
|
white
| 28.398438
| 54
| 0.633911
| 0.530884
| 5
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 18
| 71
| 15.599609
| 74
| 11
| 37.79688
| 146.65625
| 2.399902
| 3.199707
| 4.099609
| 138
| 7.469727
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 18
| 1
|
58.29199
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 100
| 20,454.547
| 13,545.375
| null | 41
|
white
| 46.195313
| 77
| 0.003
| 0
| 6
| 0
| 0
|
no
| 0
| 0
|
dnr before sadm
| -5
| 70
| 15.599609
| 0
| 0
| 35.5
| 228
| null | 0.399963
| 3.5
| 124
| 7.15918
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 4
| 1
|
65.86395
|
male
| 0
| 17
|
Lung Cancer
|
Cancer
| 1
| null |
under $11k
| 0
| 15,353.195
| 10,907.9844
| null | 6.666664
|
black
| 13.898438
| 40
| 0.762939
| 0.511963
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.1
|
dnr after sadm
| 2
| 75
| 11
| 88
| 28
| 37.19531
| 228.5625
| 4
| 0.5
| 0.799927
| 130
| 7.489258
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 99
| 1
|
59.064
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 9
|
$25-$50k
| 0
| 6,036.098
| 3,612.1367
| null | 14
|
white
| 15.398438
| 9
| 0.846924
| 0.661987
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 5
| 109
| 5.899414
| 80
| 24
| 38.19531
| null | 3.199707
| 0.899902
| 0.899902
| 139
| null | null | null | null | 0
| 0
| null | 0
| 418
| 1
|
35.57797
|
male
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 16,707.297
| 10,840.7656
| null | 12.5
|
black
| 28.5
| 27
| 0.900879
| 0.832886
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 13
| 70
| 9.798828
| 120
| 30
| 36
| 295.625
| 2.699707
| null | 0.899902
| 133
| 7.349609
| null | null | null | 0
| 5
|
no(M2 and SIP pres)
| 5
| 1,557
| 0
|
25.56899
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 15
|
under $11k
| 9
| 36,389.594
| 25,027.0312
| null | 18.333328
|
white
| 35.898438
| 57
| 0.674927
| 0.579956
| 9
| 1
| 0
|
no
| null | null |
no dnr
| 22
| 119
| 1.299805
| 114
| 12
| 35.79688
| 456.625
| 2.199707
| 0.899902
| 5.299805
| 144
| 7.439453
| null | null | null | 2
| null | null | 1.839
| 1,558
| 0
|
60.05197
|
male
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 16
| null | 0
| 4,399.648
| 2,730.6269
| null | 7
|
white
| 19.796875
| 23
| 0.792969
| 0.667969
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 4
| 71
| 6.299805
| 72
| 16
| 36.69531
| null | null | 7.299805
| 1
| 136
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.868897
| 287
| 1
|
88.19196
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 37
| 29,291.234
| 19,606.7969
| null | 21.666656
|
black
| 27.898438
| 65
| 0.45697
| 0.337952
| 1
| 0
| 1
|
no
| 0.8
| 0.6
|
dnr after sadm
| 2
| 52
| 7.299805
| 144
| 11
| 36.69531
| 240
| 2.099609
| 0.399963
| 2.299805
| 139
| 7.269531
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 711
| 1
|
48.42999
|
male
| 1
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 10
|
$11-$25k
| 61
| 22,941.047
| 15,236.8125
| null | 40
|
white
| 37.296875
| 55
| 0.197998
| 0.059998
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 3
| 75
| 12.898438
| 138
| 10
| 34.79688
| 98.32812
| 2.199707
| 2.399902
| 1.899902
| 138
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
72.78894
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| 14
|
>$50k
| 0
| 3,910.1
| 2,377.082
| null | 6
|
white
| 25.5
| 36
| 0.47699
| 0.159973
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 4
| 120
| 11.398438
| 120
| 28
| 36.09375
| null | null | 0.599976
| 1.799805
| 136
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 179
| 1
|
25.618
|
female
| 1
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 13
|
under $11k
| 37
| 47,193.688
| 30,280.5
| null | 46
|
black
| 41
| 83
| 0.458984
| 0.256958
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 10
| 59
| 15.699219
| 100
| 33
| 35.59375
| 213.3125
| 2.299805
| 20.296875
| 3.299805
| 130
| 7.439453
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 12
| 1
|
50.11398
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| 8,178.348
| 5,508.793
| null | 21
|
black
| 17.597656
| 16
| 0.915894
| 0.856934
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 115
| 5.799805
| 100
| 28
| 36.69531
| 304.75
| null | null | 0.899902
| 141
| 7.419922
| null | null | null | 0
| null | null | 0.4948
| 1,551
| 0
|
59.28497
|
male
| 1
| 17
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 42,512.125
| 27,666.9688
| null | 32.666657
|
white
| 35.398438
| 23
| 0.233978
| 0.028
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 8
| 103
| 20.199219
| 100
| 20
| 37
| 290.4375
| 2.099609
| 0.199982
| 0.5
| 138
| 7.5
| null | null | null | 4
| 6
|
<2 mo. follow-up
| 6
| 17
| 1
|
50.396
|
female
| 1
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 10
|
$11-$25k
| 0
| 134,989.125
| 83,926.1875
| null | 33.333313
|
white
| 25.097656
| 28
| 0.587891
| 0.478943
| 42
| 0
| 0
|
yes
| 0.7
| 0.4
|
dnr after sadm
| 14
| 109
| 39.195313
| 106
| 28
| 36.59375
| 160
| 2.699707
| null | 1.099854
| 137
| 7.479492
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 14
| 1
|
69.72498
|
female
| 1
| 56
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 11
|
under $11k
| 0
| 303,683.5
| 192,640.75
| null | 43.25
|
white
| 34.695313
| 36
| 0.460999
| 0.258972
| 14
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 46
| 113
| 12.599609
| 120
| 36
| 38
| 193.3125
| 2.599609
| 1.5
| 0.799927
| 148
| 7.349609
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 56
| 1
|
47.10999
|
female
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 6,076.496
| 4,425.5273
| null | 6
|
black
| 20.296875
| 29
| 0.849976
| 0.75293
| 1
| 0
| 1
|
no
| 0.7
| 0.5
|
no dnr
| 7
| 80
| 10.398438
| 100
| 20
| 38
| null | 1.599854
| 5.799805
| 0.899902
| 136
| null | null | null | null | 0
| 1
| null | 1
| 532
| 1
|
77.96899
|
female
| 1
| 19
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null |
under $11k
| 26
| 63,867.688
| 43,432.9062
| null | 36
|
white
| 35.195313
| 40
| 0.32196
| 0.138977
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 16
| 103
| 12.199219
| 96
| 36
| 36.09375
| 260
| 2.5
| 5.299805
| 0.699951
| 129
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
43.99698
|
male
| 1
| 19
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 14
| null | 9
| 42,310.281
| 27,209.7812
| null | 18.666656
|
hispanic
| 21.398438
| 20
| 0.830933
| 0.723999
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 19
| 97
| 8.199219
| 130
| 12
| 38.79688
| 496.625
| null | 1.799805
| 0.799927
| 142
| 7.5
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
19.85199
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 95,530.875
| 59,617.7812
| null | 49.5
|
white
| 43.5
| 65
| 0.56897
| 0.457947
| 8
| 0
| 0
|
no
| 0.01
| 0.000001
|
no dnr
| 8
| 63
| 20.097656
| 124
| 20
| 38.39844
| 98.32812
| 3.199707
| 21.199219
| 3.699707
| 137
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 1.882568
| 8
| 1
|
79.69098
|
female
| 1
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
under $11k
| 37
| 172,505.125
| 110,413.75
| null | 39.666657
|
white
| 28.898438
| 56
| 0.367981
| 0.25
| 17
| 0
| 0
|
no
| null | null |
dnr after sadm
| 17
| 56
| 9.599609
| 114
| 34
| 38.5
| 293.3125
| 4.099609
| 9.5
| 0.799927
| 136
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
40.34998
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 12
|
under $11k
| 0
| 34,898.594
| 22,762.2812
| null | 10
|
black
| 32.796875
| 42
| 0.724976
| 0.640991
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 19
| 87
| 13.699219
| 80
| 20
| 35.59375
| 125
| 2.799805
| 0.299988
| 8.398438
| 127
| 7.40918
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,546
| 0
|
36.90298
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 0
| 25,755.594
| 17,364.1406
| null | 24.333328
|
hispanic
| 39.09375
| 73
| 0.631958
| 0.528931
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 16
| 73
| 12.298828
| 130
| 9
| 34.89844
| 347.5625
| 2.399902
| 5.5
| 2.599609
| 131
| 7.40918
| null | null | null | 5
| 6
|
<2 mo. follow-up
| 6
| 53
| 1
|
76.51196
|
female
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| 8
| null | 0
| 6,821.75
| 4,828.9609
| null | 8
|
white
| 14.5
| 25
| 0.72998
| 0.457947
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 9
| 109
| 1.299805
| 92
| 20
| 36.79688
| null | null | null | 1.099854
| 139
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 331
| 1
|
41.629
|
male
| 0
| 38
|
Coma
|
Coma
| 0
| 8
|
$11-$25k
| 61
| 64,012.688
| 42,502.8438
| null | 22.25
|
white
| 26.199219
| 46
| 0.574951
| 0.508911
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 38
| 114
| 13.798828
| 114
| 60
| 40
| 227.5
| null | 1.199951
| 1.399902
| 144
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,238
| 1
|
40.452
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 44
| 31,204.594
| 20,957.7812
| null | 20
|
black
| 21.796875
| 14
| 0.779907
| 0.708984
| 4
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 12
| 117
| 16.097656
| 98
| 26
| 36.09375
| 260
| null | null | 0.799927
| 135
| 7.339844
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,545
| 0
|
71.96698
|
female
| 1
| 19
|
Coma
|
Coma
| 0
| 12
|
$25-$50k
| 61
| 50,624.125
| 33,906.875
| null | 34.666657
|
white
| 25.597656
| 51
| 0.286987
| 0.217987
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 10
| 137
| 15.5
| 116
| 35
| 38.5
| 372
| 2.799805
| null | 2.099609
| 134
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
43.37299
|
male
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 15
|
$25-$50k
| 100
| 21,115.188
| 12,553.6641
| null | 44
|
black
| 81.796875
| 84
| 0
| 0
| 5
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 3
| 0
| 16.898438
| 0
| 14
| 35.79688
| 273.3125
| 2.599609
| 12.599609
| 4.299805
| 149
| 7.319336
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 3
| 1
|
56.556
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 6,480.297
| 4,016.7168
| null | 10
|
white
| 24.796875
| 16
| 0.705933
| 0.421997
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 6
| 103
| 6
| 100
| 28
| 38.5
| null | 2.899902
| 1.199951
| 0.599976
| 140
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 283
| 1
|
82.58197
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
| null | 26
| 63,105.875
| 39,187.0312
| null | 31.5
|
white
| 48.5
| 62
| 0.018997
| 0.004
| 6
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 7
| 47
| 17
| 106
| 10
| 36.09375
| 260
| null | 10
| 6.099609
| 123
| 7.319336
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
36.74197
|
male
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 0
| 12
| null | 0
| 36,980.094
| 24,034.9375
| null | 37
|
black
| 30.199219
| 42
| 0.517944
| 0.40094
| 8
| 0
| 0
|
yes
| 0.5
| 0.1
|
dnr after sadm
| 8
| 63
| 14.5
| 140
| 32
| 35.69531
| 146.65625
| null | null | 1.099854
| 143
| 7.469727
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
48.30698
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 33,070.469
| 20,807.9219
| null | 12.333328
|
white
| 27.699219
| 32
| 0.797974
| 0.730957
| 2
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 17
| 110
| 28.199219
| 50
| 16
| 37
| 443.4375
| 2.799805
| null | 5
| 131
| 7.40918
| null | null | null | null | null | null | 2.640137
| 1,540
| 0
|
65.13599
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$25-$50k
| 0
| 57,069.969
| 36,112.25
| null | 31.333328
|
white
| 38.195313
| 67
| 0.421997
| 0.302979
| 1
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 15
| 53
| 20
| 116
| 28
| 39
| 194
| 3.299805
| 4.799805
| 2.199707
| 130
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,178
| 1
|
48.931
|
male
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
|
>$50k
| 0
| 79,986.812
| 54,028.7812
| null | 27
|
black
| 14.199219
| 10
| 0.910889
| 0.878906
| 9
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 37
| 111
| 13.798828
| 74
| 8
| 38.89844
| 304
| 3.199707
| 0.299988
| 1
| 138
| 7.369141
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,538
| 0
|
73.54999
|
male
| 1
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 154,653.25
| 101,745.938
| null | 38.5
|
white
| 34.898438
| 85
| 0.540894
| 0.426941
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
no dnr
| 40
| 136
| 14.599609
| 158
| 29
| 35.59375
| 200
| 1.599854
| 3.299805
| 5.5
| 138
| 7.519531
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 40
| 1
|
77.86694
|
male
| 0
| 192
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$11-$25k
| 9
| 492,828
| 334,111.75
| null | 38.75
|
white
| 28.398438
| 47
| 0.542969
| 0.428955
| 14
| 1
| 0
|
no
| 0.6
| 0.6
|
dnr after sadm
| 82
| 75
| 21.597656
| 140
| 9
| 38.29688
| 187.5
| null | null | 2.199707
| 151
| 7.389648
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.616211
| 1,537
| 0
|
67.54297
|
female
| 1
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 13
|
under $11k
| 0
| 7,606.227
| 5,431.7109
| null | 11
|
white
| 23
| 25
| 0.815918
| 0.701904
| 1
| 0
| 0
|
no
| 0.3
| 0.15
|
dnr after sadm
| 1
| 80
| 3.699707
| 106
| 24
| 37.39844
| 164
| null | 0.299988
| 0.399963
| 136
| 7.25
| null | null | null | 5
| 5
|
<2 mo. follow-up
| 5
| 11
| 1
|
76.61597
|
male
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 44
| 54,942.594
| 35,570.4375
| null | 30.5
|
white
| 20.796875
| 21
| 0.630981
| 0.527954
| 4
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 81
| 13.898438
| 64
| 40
| 39.79688
| 410
| 3.099609
| 0.899902
| 0.799927
| 146
| 7.469727
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 12
| 1
|
56.91998
|
male
| 1
| 8
|
Coma
|
Coma
| 1
| 16
|
>$50k
| 100
| 39,522.688
| 27,228.875
| null | 29.5
|
white
| 22.296875
| 23
| 0.085999
| 0.049995
| 16
| 0
| 0
|
metastatic
| 0.6
| 0.3
|
dnr after sadm
| 2
| 111
| 12.199219
| 116
| 22
| 36.59375
| 316.625
| 1.799805
| 0.699951
| 0.5
| 135
| 7.429688
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 8
| 1
|
42.46997
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 9
| 22,030.047
| 15,530.1797
| null | 14
|
white
| 15.199219
| 12
| 0.919922
| 0.890991
| 2
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 11
| 101
| 5.799805
| 70
| 12
| 38.09375
| 304.75
| null | 0.199982
| 0.699951
| 136
| 7.439453
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,534
| 0
|
34.56299
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 6,135.598
| 3,612.6094
| null | 12
|
white
| 15
| 7
| 0.803955
| 0.582886
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 87
| 11.898438
| 84
| 20
| 36.09375
| 266.625
| 3.699707
| 0.5
| 0.699951
| 140
| 7.469727
| null | null | null | null | null | null | 1.915527
| 427
| 1
|
79.19196
|
male
| 0
| 44
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
>$50k
| 0
| 99,666.938
| 66,717.125
| null | 24.25
|
white
| 33.695313
| 48
| 0.492981
| 0.375977
| 3
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 44
| 52
| 16.296875
| 74
| 26
| 37.59375
| 179.5625
| 2.5
| null | 4.299805
| 130
| 7.359375
| null | null | null | null | 0
|
SIP>=30
| 0
| 390
| 1
|
80.60498
|
male
| 0
| 36
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 24
|
$25-$50k
| 0
| 36,915.625
| 25,450.3594
| null | 10.5
|
white
| 22.898438
| 29
| 0.646973
| 0.467957
| 2
| 0
| 0
|
yes
| null | null |
no dnr
| 36
| 87
| 15.599609
| 64
| 28
| 36.59375
| 145.6875
| null | 0.299988
| 1
| 134
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 193
| 1
|
44.39398
|
male
| 1
| 3
|
Coma
|
Coma
| 0
| null | null | 100
| 11,347.344
| 7,430.0469
| null | 25
|
black
| 80
| 73
| 0
| 0
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 3
| 0
| 20.796875
| 0
| 0
| 35
| 544
| null | null | 2.5
| 154
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 1.374268
| 3
| 1
|
51.504
|
male
| 0
| 171
|
Coma
|
Coma
| 0
| null | null | 94
| 156,180.375
| 108,716.25
| null | 27.25
|
black
| 14.599609
| 11
| 0.630981
| 0.569946
| 1
| 0
| 0
|
no
| 0.4
| 0.1
|
dnr after sadm
| 36
| 81
| 7.5
| 66
| 26
| 38.29688
| 303.3125
| 2.899902
| null | 1.199951
| 145
| 7.439453
| null | null | null | null | null | null | 2.008789
| 259
| 1
|
75.35699
|
male
| 1
| 62
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 0
| 169,118.25
| 111,419.812
| null | 31.5
|
black
| 29.5
| 59
| 0.560913
| 0.448975
| 21
| 1
| 0
|
no
| null | null |
dnr after sadm
| 59
| 65
| 0.199982
| 110
| 8
| 36.79688
| 233.3125
| 2.399902
| null | 0.599976
| 134
| 7.5
| null | null | null | null | 7
| null | 7
| 62
| 1
|
67.52399
|
male
| 0
| 44
|
Coma
|
Coma
| 1
| 8
| null | 37
| 141,597.75
| 92,144.4375
| null | 34.5
|
black
| 20.699219
| 52
| 0.506958
| 0.435974
| 8
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 44
| 75
| 8.398438
| 156
| 37
| 38.5
| 305.6875
| 2.399902
| 0.399963
| 1.5
| 138
| 7.40918
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,529
| 0
|
48.728
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 10,446.398
| 7,117.5312
| null | 8.5
|
black
| 22.699219
| 33
| 0.878906
| 0.797974
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 10
| 106
| 5.699219
| 84
| 20
| 35.79688
| null | 3.099609
| 2.199707
| 1.699951
| 134
| null | null | null | null | 0
| null | null | 0.4948
| 849
| 1
|
66.80597
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 7,554.199
| 5,042.9414
| null | 8
|
white
| 31.796875
| 17
| 0.311951
| 0.056
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.4
|
no dnr
| 8
| 100
| 14.798828
| 100
| 24
| 36.59375
| 420
| 2.299805
| 1.299805
| 1
| 144
| 7.389648
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 320
| 1
|
68.70898
|
male
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
$11-$25k
| 0
| 94,199.812
| 59,171.6875
| null | 38
|
white
| 29.097656
| 36
| 0.705933
| 0.616943
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 19
| 115
| 12.798828
| 124
| 33
| 37.19531
| 108.32812
| null | 0.799927
| 0.899902
| 140
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 23
| 1
|
40.99899
|
male
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
| null | 0
| 13,750.117
| 9,702.7188
| null | 9
|
black
| 29.796875
| 36
| 0.823975
| 0.713989
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 120
| 5.299805
| 85
| 22
| 36
| 300
| 2.099609
| 0.399963
| 3.299805
| 142
| 7.449219
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 444
| 1
|
52.97198
|
male
| 1
| 8
|
Coma
|
Coma
| 0
| 11
| null | 100
| 18,601.594
| 12,105.8828
| null | 20.5
|
black
| 17.898438
| 6
| 0.505981
| 0.434998
| 1
| 0
| 0
|
no
| 0.02
| 0.000008
|
no dnr
| 8
| 96
| 17.199219
| 52
| 12
| 36.69531
| 290
| null | 0.299988
| 1.099854
| 136
| 7.5
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
66.64496
|
female
| 0
| 78
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 269,475.5
| 176,331.75
| null | 42.75
|
black
| 40.09375
| 76
| 0.199982
| 0.106995
| 13
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 78
| 51
| 20
| 104
| 38
| 38.79688
| 208
| 3.799805
| 12.099609
| 2.099609
| 131
| 7.399414
| null | null | null | null | null | null | 2.439453
| 1,527
| 0
|
62.69998
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
$11-$25k
| 26
| 55,241.594
| 36,863.125
| null | 14
|
white
| 24.898438
| 19
| 0.665894
| 0.56897
| 7
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 14
| 100
| 16.296875
| 124
| 14
| 36
| 255.53125
| null | null | 0.699951
| 147
| 7.479492
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,526
| 0
|
49.45099
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
| null | 9
| 92,412.438
| 56,558.4062
| null | 36
|
white
| 19.597656
| 28
| 0.852905
| 0.802979
| 6
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 23
| 133
| 8
| 64
| 12
| 37.39844
| 292
| null | null | 0.399963
| 132
| 7.469727
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 297
| 1
|
61.99298
|
female
| 1
| 13
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 7
|
under $11k
| 0
| 58,915.594
| 38,120.125
| null | 49.5
|
white
| 35.695313
| 50
| 0.399963
| 0.279968
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 13
| 50
| 25.296875
| 110
| 20
| 36.59375
| 54
| 2.399902
| 0.099991
| 1.099854
| 139
| 7.349609
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 13
| 1
|
39.82999
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
under $11k
| 0
| 28,210.188
| 19,233.4688
| null | 22
|
black
| 22.296875
| 43
| 0.891968
| 0.852905
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 142
| 6.399414
| 114
| 28
| 38.29688
| 160
| 2.599609
| 0.5
| 1.199951
| 137
| 7.479492
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,525
| 0
|
41.91898
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 4,684.547
| 2,984.4473
| null | 14
|
black
| 21.097656
| 14
| 0.803955
| 0.582886
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 73
| 5.699219
| 104
| 24
| 38.29688
| null | 2.899902
| 0.199982
| 1.199951
| 139
| null | null | null | null | null | null | null | 1.804199
| 1,524
| 0
|
70.52197
|
male
| 1
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 100
| 93,077.688
| 60,741.5312
| null | 32.333313
|
white
| 28.199219
| 30
| 0.188995
| 0.098999
| 4
| 0
| 0
|
no
| 0.3
| 0.15
|
dnr after sadm
| 19
| 65
| 14.599609
| 118
| 23
| 36.79688
| 157.5
| null | 2.599609
| 1.099854
| 152
| 7.509766
| null | null | null | null | null |
<2 mo. follow-up
| 3.044922
| 20
| 1
|
59.95099
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 6
|
under $11k
| 9
| 37,907.438
| 24,762.9375
| null | 27.5
|
white
| 29.199219
| 40
| 0.694946
| 0.603882
| 2
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 9
| 109
| 9.298828
| 126
| 32
| 35.39844
| 168.5625
| null | null | 1.599854
| 138
| 7.469727
| null | null | null | 5
| 7
|
SIP>=30
| 7
| 493
| 1
|
63.064
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 70,353
| 45,316.9688
| null | 31.333328
|
white
| 27.097656
| 35
| 0.738892
| 0.656982
| 3
| 1
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 23
| 67
| 11.398438
| 120
| 17
| 37.79688
| 141.65625
| 2.5
| 0.599976
| 1.199951
| 156
| 7.419922
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,522
| 0
|
52.70898
|
female
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| 10
|
under $11k
| 0
| 13,646.242
| 9,036.8516
| null | 20.5
|
white
| 30.597656
| 24
| 0.394958
| 0.099991
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 9
| 77
| 7.199219
| 124
| 24
| 38.59375
| 292
| 2.399902
| 0.399963
| 0.699951
| 140
| 7.389648
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 29
| 1
|
31.28299
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 6
| 12
| null | 44
| 52,990.125
| 34,947.8438
| null | 40
|
white
| 35.296875
| 63
| 0.591919
| 0.483948
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 6
| 105
| 19.398438
| 124
| 30
| 38.19531
| 303.3125
| 2.599609
| 20
| 2.5
| 145
| 7.489258
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 12
| 1
|
57.21597
|
female
| 0
| 53
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 0
| 173,402.5
| 116,365.75
| null | 37
|
white
| 30
| 44
| 0.740967
| 0.659912
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 53
| 129
| 8.199219
| 124
| 10
| 38.39844
| 146
| 2.599609
| 0.799927
| 5
| 131
| 7.359375
| null | null | null | null | 1
| null | 1
| 1,521
| 0
|
53.33298
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 57,244.219
| 36,879.25
| null | 33
|
white
| 28.597656
| 26
| 0.745972
| 0.665894
| 4
| 0
| 0
|
no
| 0.3
| 0.2
|
no dnr
| 10
| 70
| 6
| 130
| 18
| 38.29688
| 93.32812
| null | null | 0.799927
| 135
| 7.389648
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 10
| 1
|
56.04898
|
male
| 0
| 38
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 67,626.438
| 44,162.25
| null | 26
|
white
| 34.398438
| 52
| 0.420959
| 0.301941
| 2
| 0
| 0
|
yes
| null | null |
no dnr
| 38
| 95
| 0.799927
| 136
| 9
| 38.29688
| 185
| null | null | 2.599609
| 144
| 7.299805
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 742
| 1
|
54.92099
|
male
| 0
| 148
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 7
| null | 37
| 244,624.625
| 159,445.375
| null | 26.5
|
white
| 31.199219
| 87
| 0.582886
| 0.473999
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 148
| 77
| 11
| 70
| 38
| 36.09375
| 312
| 1.799805
| 9.599609
| 9.199219
| 132
| 7.399414
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,518
| 0
|
59.29898
|
male
| 0
| 14
|
Lung Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 16,175.344
| 10,839.3125
| null | 13.5
|
white
| 14.699219
| 9
| 0.761963
| 0.510986
| 1
| 0
| 0
|
metastatic
| 1
| 0.8
|
no dnr
| 14
| 95
| 10.798828
| 76
| 16
| 36.89844
| null | null | 0.5
| 0.799927
| 138
| null | null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 67
| 1
|
53.03198
|
male
| 0
| 261
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
$11-$25k
| 0
| null | null | null | 20.5
|
white
| 21
| 21
| 0.882935
| 0.804932
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 261
| 67
| 7.899414
| 112
| 15
| 35.59375
| 428.5625
| null | 0.799927
| 1.099854
| 134
| 7.509766
| null | null | null | 3
| 3
|
no(M2 and SIP pres)
| 3
| 1,517
| 0
|
61.55499
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
|
$25-$50k
| 0
| 35,619.375
| 21,743.2031
| null | 23.666656
|
white
| 25.296875
| 53
| 0.800903
| 0.734985
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 15
| 172
| 6.5
| 136
| 47
| 35.59375
| 233.3125
| 1.899902
| 0.399963
| 1.399902
| 141
| 7.339844
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 770
| 1
|
77.659
|
male
| 1
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 37,074.156
| 21,822.0469
| null | 31
|
white
| 32.59375
| 42
| 0.578979
| 0.384949
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 63
| 7.199219
| 106
| 15
| 35.69531
| 167.5
| null | null | 2.699707
| 128
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
68.18597
|
male
| 0
| 29
|
Lung Cancer
|
Cancer
| 2
| 13
|
$25-$50k
| 0
| 32,881.094
| 22,047.1562
| null | 10.5
|
white
| 15.599609
| 11
| 0.726929
| 0.453979
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
no dnr
| 29
| 83
| 13.099609
| 80
| 20
| 37.5
| null | null | 0.199982
| 0.699951
| 134
| null | null | null | null | 3
| 2
|
adl>=4 (>=5 if sur)
| 2
| 99
| 1
|
63.83298
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 5,728.848
| 3,659.584
| null | 8
|
white
| 18.097656
| 9
| 0.804932
| 0.582886
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 6
| 99
| 4.5
| 76
| 22
| 36.69531
| null | 3.099609
| null | 1
| 142
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 930
| 1
|
43.58698
|
female
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 116,817.688
| 74,611
| null | 28.25
|
white
| 30.296875
| 39
| 0.583984
| 0.473999
| 19
| 0
| 0
|
metastatic
| 0.85
| 0.8
|
no dnr
| 35
| 114
| 15.898438
| 134
| 10
| 38.5
| 140
| 2.799805
| 5.5
| 0.799927
| 142
| 7.459961
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 362
| 1
|
89.23199
|
male
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 4
|
under $11k
| 0
| 33,702.719
| 21,365.2656
| null | 25
|
black
| 29.097656
| 49
| 0.494995
| 0.293945
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
no dnr
| 18
| 63
| 5.699219
| 130
| 6
| 37
| 117.76562
| null | null | 1.799805
| 146
| 7.489258
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 201
| 1
|
69.98499
|
female
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 7,079.297
| 5,065.1289
| null | 6
|
white
| 30.199219
| 27
| 0.535889
| 0.212982
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.2
|
no dnr
| 8
| 122
| 31.097656
| 76
| 28
| 35.79688
| null | 2.699707
| 0.099991
| 0.599976
| 137
| 7.479492
| null | null | null | 2
| 0
|
adl>=4 (>=5 if sur)
| 0
| 87
| 1
|
65.62396
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 3
| null | 0
| 43,053.844
| 26,501.4375
| null | 20.5
|
black
| 21.199219
| 18
| 0.682983
| 0.588989
| 13
| 0
| 0
|
metastatic
| 0.8
| 0.8
|
dnr after sadm
| 8
| 75
| 10
| 130
| 24
| 36.5
| null | null | null | 0.799927
| 139
| null | null | null | null | null | 3
| null | 3
| 64
| 1
|
23.19199
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 24,461.188
| 16,495.3906
| null | 27.5
|
black
| 27.199219
| 34
| 0.883911
| 0.842896
| 1
| 0
| 0
|
no
| 0.99
| 0.98
|
no dnr
| 11
| 122
| 15.199219
| 114
| 41
| 37.69531
| 220
| null | null | 0.199982
| 136
| 7.589844
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 82
| 1
|
60.646
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 61
| 79,154.938
| 46,919.625
| null | 53
|
white
| 37.195313
| 48
| 0.152985
| 0.07399
| 13
| 0
| 0
|
no
| null | null |
dnr after sadm
| 4
| 61
| 16.597656
| 124
| 8
| 36
| 160
| 2.5
| 3.099609
| 5.399414
| 131
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 3.036621
| 5
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.